Local ablation for hepatocellular carcinoma in Taiwan
SM Lin - Liver cancer, 2013 - karger.com
Hepatocellular carcinoma (HCC) is the second commonest cancer in Taiwan. The national
surveillance program can detect HCC in its early stages, and various curative modalities …
surveillance program can detect HCC in its early stages, and various curative modalities …
[HTML][HTML] Diagnóstico y tratamiento del carcinoma hepatocelular. Actualización del documento de consenso de la AEEH, AEC, SEOM, SERAM, SERVEI y SETH
M Reig, A Forner, MA Ávila, C Ayuso, B Mínguez… - Medicina Clínica, 2021 - Elsevier
Hepatocellular carcinoma (HCC) is the most common primary liver neoplasm and one of the
most common causes of death in patients with cirrhosis of the liver. In parallel, with …
most common causes of death in patients with cirrhosis of the liver. In parallel, with …
[HTML][HTML] Therapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRI
Y Minami, N Nishida, M Kudo - World Journal of Gastroenterology …, 2014 - ncbi.nlm.nih.gov
Radiofrequency ablation (RFA) is commonly applied for the treatment of hepatocellular
carcinoma (HCC) because of the facile procedure, and the safety and effectiveness for the …
carcinoma (HCC) because of the facile procedure, and the safety and effectiveness for the …
Diagnosis and treatment of hepatocellular carcinoma. Update consensus document from the AEEH, SEOM, SERAM, SERVEI and SETH
A Forner, M Reig, M Varela, M Burrel, J Feliu… - … Clínica (English Edition), 2016 - Elsevier
El carcinoma hepatocelular es la neoplasia primaria de hígado más común y una de las
causas de muerte más frecuentes en los pacientes afectos de cirrosis hepática …
causas de muerte más frecuentes en los pacientes afectos de cirrosis hepática …
After insufficient radiofrequency ablation, tumor-associated endothelial cells exhibit enhanced angiogenesis and promote invasiveness of residual hepatocellular …
J Kong, L Kong, J Kong, S Ke, J Gao, X Ding… - Journal of Translational …, 2012 - Springer
Background The mechanism regarding rapid progression of residual hepatocellular
carcinoma (HCC) after insufficient radiofrequency ablation (RFA) has been preliminarily …
carcinoma (HCC) after insufficient radiofrequency ablation (RFA) has been preliminarily …
Combination therapy of radiofrequency ablation and transarterial chemoembolization for unresectable hepatocellular carcinoma: a retrospective study
C Tang, J Shen, W Feng, Y Bao, X Dong, Y Dai… - Medicine, 2016 - journals.lww.com
The treatment efficacy of unresectable hepatocellular carcinoma (HCC) is still not promising.
This study aimed to compare the efficacy and safety of radiofrequency ablation (RFA) …
This study aimed to compare the efficacy and safety of radiofrequency ablation (RFA) …
Multimodal percutaneous thermal ablation of small hepatocellular carcinoma: predictive factors of recurrence and survival in western patients
M Hermida, C Cassinotto, L Piron, S Aho-Glélé… - Cancers, 2020 - mdpi.com
Background: To identify the predictive factors of recurrence and survival in an unselected
population of Western patients who underwent multimodal percutaneous thermal ablation …
population of Western patients who underwent multimodal percutaneous thermal ablation …
Surgical treatment of hepatocellular carcinoma: multicenter competing-risk analysis of tumor-related death following liver resection and transplantation under an …
S Di Sandro, C Sposito, M Ravaioli, A Lauterio… - …, 2023 - journals.lww.com
Background. Early-stage hepatocellular carcinoma could benefit from upfront liver resection
(LR) or liver transplantation (LT), but the optimal strategy in terms of tumor-related outcomes …
(LR) or liver transplantation (LT), but the optimal strategy in terms of tumor-related outcomes …
Radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of overall survival and recurrence-free survival
AC Gardini, G Marisi, M Canale, FG Foschi… - OncoTargets and …, 2018 - Taylor & Francis
Background and aims So far, no randomized trial or meta-analysis has been conducted on
overall survival (OS) and recurrence-free survival (RFS) factors in patients treated with …
overall survival (OS) and recurrence-free survival (RFS) factors in patients treated with …
Radiofrequency ablation for hepatic oligometastatic pancreatic cancer: an analysis of safety and efficacy
YQ Hua, P Wang, XY Zhu, YH Shen, K Wang, WD Shi… - Pancreatology, 2017 - Elsevier
Objectives This study was to evaluate the value of radiofrequency ablation (RFA) in the
treatment of pancreatic cancer with synchronous liver oligometastasis. Methods 102 patients …
treatment of pancreatic cancer with synchronous liver oligometastasis. Methods 102 patients …